ArticleCureus2025
Association Between Third-Trimester Ultrasonography With Histopathological Changes in the Placenta Among Mothers With Gestational Diabetes Mellitus.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Altered Placental Ezrin Expression in Gestational Diabetes Mellitus: An Immunohistochemical and Bioinformatic Analysis.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Gestational diabetes mellitus (GDM) is a prevalent metabolic disorder during pregnancy, associated with significant maternal and fetal complications. GDM affects placental structure and function, potentially compromising fetal development. Third-trimester ultrasonography (USG) serves as a non-invasive tool for fetal and placental assessment, while histopathological examination provides definitive evidence of placental changes. This study aimed to evaluate the correlation between third-trimester USG findings and placental histopathological changes in GDM pregnancies. Methodology A hospital-based observational study was conducted over 18 months at a tertiary care center in Chennai. A total of 85 pregnant women diagnosed with GDM after 28 weeks of gestation were included. All participants underwent third-trimester USG to assess placental thickness, estimated fetal weight (EFW), amniotic fluid index (AFI), and placental grading. After delivery, placentas were collected and examined histopathologically for changes such as syncytial knots, chorangiosis, fibrinoid necrosis, and intervillous thrombosis. Data were analyzed using SPSS (IBM SPSS Statistics for Windows, IBM Corp., Version 26, Armonk, NY), and associations between USG and histopathological findings were assessed using independent t-tests. Results A total of 85 women with gestational diabetes were studied. Nearly half were aged 26-30 years (42, 49.4%), while 20 (23.5%) were 31-35 years. Management was most commonly with oral hypoglycemic agents (40, 47.1%), followed by medical nutrition therapy (21, 24.7%). Antenatal steroids were administered in 38 (44.8%). Most USG examinations were at 31-32 weeks (40, 47.1%). Term deliveries (37-38 weeks) occurred in 77 (90.6%), with 52 (61.2%) vaginal and 33 (38.8%) caesarean births. Placental grading showed Grade 3 in 78 (91.7%). Histopathology frequently revealed syncytial knots, chorangiosis, fibrinoid necrosis, and intervillous thrombosis, significantly associated with increased placental thickness and EFW. Conclusion Third-trimester USG findings, particularly increased placental thickness and EFW, correlate significantly with histopathological changes in GDM placentas. These findings underscore the value of antenatal USG as a predictive tool for placental pathology and potential adverse outcomes in GDM pregnancies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.